Broadening the phenotypic spectrum of EVEN-PLUS syndrome through identification of HSPA9 pathogenic variants in the original EVE dysplasia family and two sibs with milder facial phenotype.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
09 2022
Historique:
revised: 25 05 2022
received: 05 10 2021
accepted: 13 06 2022
pubmed: 3 7 2022
medline: 17 8 2022
entrez: 2 7 2022
Statut: ppublish

Résumé

EVEN-PLUS syndrome is a rare autosomal recessive disorder caused by biallelic pathogenic variants in the mitochondrial chaperone called mortalin, encoded by HSPA9. This genetic disorder, presenting with several overlapping features with CODAS syndrome, is characterized by the involvement of the Epiphyses, Vertebrae, Ears, and Nose (EVEN), PLUS associated findings. Only five individuals presenting with the EVEN-PLUS phenotype and biallelic variants in HSPA9 have been published. Here, we expand the phenotypic and molecular spectrum associated with this disorder, reporting two sibs with a milder phenotype and compound heterozygous pathogenic variants (a recurrent variant and a novel one). Also, we confirm a homozygous pathogenic variant in the family originally reported as EVE dysplasia.

Identifiants

pubmed: 35779070
doi: 10.1002/ajmg.a.62883
doi:

Substances chimiques

HSP70 Heat-Shock Proteins 0
HSPA9 protein, human 0
Mitochondrial Proteins 0

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2819-2824

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Amiel, J., Cormier-Daire, V., Journeau, P., Mussat, P., Munnich, A., & Lyonnet, S. (1999). Epiphyseal, vertebral, and ear (EVE) dysplasia: A new syndrome? Journal of Medical Genetics, 36(7), 561-564. https://doi.org/10.1136/jmg.36.7.561
Moseng, M. A., Nix, J. C., & Page, R. C. (2019). Biophysical consequences of EVEN-PLUS syndrome mutations for the function of mortalin. Journal of Physical Chemistry B, 123(16), 3383-3396. https://doi.org/10.1021/acs.jpcb.9b00071
Nagrani, D. G., Kurniawan, A., Wahyuni, L. K., Xavier, B. C., Furga, A. S., & Sjarif, D. R. (2018). Postural and gait abnormality in Even-Plus syndrome. Journal of Molecular and Genetic Medicine, 12(2), 1-5. https://doi.org/10.4172/1747-0862.1000350
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Royer-Bertrand, B., Castillo-Taucher, S., Moreno-Salinas, R., Cho, T.-J., Chae, J.-H., Choi, M., Kim, O. H., Dikoglu, E., Campos-Xavier, B., Girardi, E., Superti-Furga, G., Bonafé, L., Rivolta, C., Unger, S., & Superti-Furga, A. (2015). Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia. Scientific Reports, 5, 17154. https://doi.org/10.1038/srep17154
Younger, G., Vetrini, F., Weaver, D. D., Lynnes, T. C., Treat, K., Pratt, V. M., & Torres-Martinez, W. (2020). EVEN-PLUS syndrome: A case report with novel variants in HSPA9 and evidence of HSPA9 gene dysfunction. American Journal of Medical Genetics, Part A, 182(11), 2501-2507. https://doi.org/10.1002/ajmg.a.61808

Auteurs

Marta Pacio-Miguez (M)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.

Manuel Parrón-Pajares (M)

Servicio de Radiodiagnóstico. Hospital Universitario La Paz, Madrid, Spain.
Skeletal Dysplasia Multidisciplinary Unit (UMDE) and European Reference Network on Rare Bone Diseases ERN-BOND, Hospital Universitario La Paz, Madrid, Spain.

Christopher T Gordon (CT)

INSERM U1163, Université de Paris, Institut Imagine, Paris, France.
Service de Génomique des Maladies Rares, Hôpital Necker Enfants Malades, APHP, Paris, France.

Fernando Santos-Simarro (F)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
Skeletal Dysplasia Multidisciplinary Unit (UMDE) and European Reference Network on Rare Bone Diseases ERN-BOND, Hospital Universitario La Paz, Madrid, Spain.
ITHACA-European Reference Network, Madrid, Spain.

Carmen Rodríguez Jiménez (C)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.

Rocio Mena (R)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.

Inmaculada Rueda Arenas (I)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.

Victoria Eugenia F Montaño (VE)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.

María Fernández (M)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.

Mario Solís (M)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.

Ángela Del Pozo (Á)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.

Jeanne Amiel (J)

INSERM U1163, Université de Paris, Institut Imagine, Paris, France.
Service de Génomique des Maladies Rares, Hôpital Necker Enfants Malades, APHP, Paris, France.

Sixto García-Miñaur (S)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
ITHACA-European Reference Network, Madrid, Spain.

María Palomares-Bralo (M)

Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain.
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
ITHACA-European Reference Network, Madrid, Spain.
Universidad Rey Juan Carlos, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH